Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Effects of Resmetirom on Noninvasive Endpoints in a 36-Week Phase 2 Active Treatment Extension Study in Patients With NASH.
Hepatol Commun. 2021 Jan 4;5(4):573-588. doi: 10.1002/hep4.1657. eCollection 2021 Apr.
Hepatol Commun. 2021.
PMID: 33860116
Free PMC article.
Clinical Trial.
Pegbelfermin (BMS-986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study.
Charles ED, Neuschwander-Tetri BA, Pablo Frias J, Kundu S, Luo Y, Tirucherai GS, Christian R.
Charles ED, et al. Among authors: pablo frias j.
Obesity (Silver Spring). 2019 Jan;27(1):41-49. doi: 10.1002/oby.22344. Epub 2018 Dec 6.
Obesity (Silver Spring). 2019.
PMID: 30520566
Free PMC article.
Clinical Trial.
Item in Clipboard
Impact of lixisenatide dose range on clinical outcomes with fixed-ratio combination iGlarLixi in patients with type 2 diabetes.
Pablo Frias J, Lorenz M, Roberts M, Dex T, Schmider W, Hurst W, Skolnik N.
Pablo Frias J, et al.
Curr Med Res Opin. 2019 Apr;35(4):689-695. doi: 10.1080/03007995.2018.1541316. Epub 2018 Dec 6.
Curr Med Res Opin. 2019.
PMID: 30360647
Item in Clipboard
Efficacy and safety of the second generation basal insulin analogs in type 2 diabetes mellitus: A critical appraisal.
Hernando VU, Pablo FJ.
Hernando VU, et al.
Diabetes Metab Syndr. 2019 May-Jun;13(3):2126-2141. doi: 10.1016/j.dsx.2019.05.001. Epub 2019 May 12.
Diabetes Metab Syndr. 2019.
PMID: 31235147
Review.
Item in Clipboard
Cite
Cite